Synergistic effect of combining dual enkephalinase inhibitor <scp>PL37</scp> and sumatriptan in a preclinical model of migraine

Jeanne Rossignol, Tanja Ouimet, Hervé Poras, Radhouane Dallel, Philippe Luccarini

Open source

DOI
10.1111/head.14681
Published
2024-02-22
Container
Headache: The Journal of Head and Face Pain
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/head.14681,
  title = {Synergistic effect of combining dual enkephalinase inhibitor
                    <scp>PL37</scp>
                    and sumatriptan in a preclinical model of migraine},
  author = {Jeanne Rossignol and Tanja Ouimet and Hervé Poras and Radhouane Dallel and Philippe Luccarini},
  year = {2024},
  journal = {Headache: The Journal of Head and Face Pain},
  doi = {10.1111/head.14681},
  url = {https://doi.org/10.1111/head.14681}
}

RIS

TY  - JOUR
TI  - Synergistic effect of combining dual enkephalinase inhibitor
                    <scp>PL37</scp>
                    and sumatriptan in a preclinical model of migraine
AU  - Jeanne Rossignol
AU  - Tanja Ouimet
AU  - Hervé Poras
AU  - Radhouane Dallel
AU  - Philippe Luccarini
PY  - 2024
JO  - Headache: The Journal of Head and Face Pain
DO  - 10.1111/head.14681
UR  - https://doi.org/10.1111/head.14681
ER  - 

APA

Rossignol, J., Ouimet, T., Poras, H., Dallel, R., & Luccarini, P. (2024). Synergistic effect of combining dual enkephalinase inhibitor <scp>PL37</scp> and sumatriptan in a preclinical model of migraine. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14681

Source records